Retour
BioInvent International AB (publ) (BOVNF) Gagner
Graphique du cours de l'action BOVNF
BOVNF Gagner
BioInvent International AB (publ)
$3.28
0%
$0
À partir d'aujourd'hui :Mar 24, 14:56:07 GMT-4
Statistiques clés
Clôture préc.
$3.28
Prix d'ouverture
$4.7
Plage de la journée
$3.28 - $4.7
Plage de 52 semaines
$3.28 - $4.7
Volume
908
Volume moyen
0
Rendement en dividend
--
BPA (TTM)
-0.47
Capitalisation boursière
$216.4M
Qu’est-ce que BIOINVENT INTERNATIONAL AB ?
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 109 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.